Hólyagrák: vizsgálatok itt: Ausztria
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 45 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07222488 · EU 2025-520467-40-00 - 3. fázisTaking peopleA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
- Where
- Graz, Innsbruck, Leopoldsdorf (Wien), Linz, Salzburg
- Életkor
- 18 év and over
- People
- 641 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06319820 - 2/3. fázisTaking peopleDato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
- Where
- Graz, Innsbruck, Krems An Der Donau, Linz, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 343 worldwide
- Run by
- Daiichi Sankyo Inc.
See details and how to join2024-516906-47-00 · EU 2024-516906-47-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Graz, Vienna
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 2/3. fázisTaking peopleStudy of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Where
- Graz, Krems, Linz, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 630 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07129993 - 2/3. fázisTaking peoplePhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Innsbruck, Vienna
- Életkor
- 18 év and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762 - 1/2. fázisTaking peopleClofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 50
- Run by
- Ekaterina Laukhtina
See details and how to joinNCT07034053 - 2. fázisTaking peopleChemoablation for Low-Grade Bladder Cancer
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 47
- Run by
- Ekaterina Laukhtina
See details and how to joinNCT07019220 - 2. fázisTaking peopleCOBRA - Chemoablation for Low Grade Bladder Cancer: A single arm, prospective, open-label, investigator-initiated Phase 2 study
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 47
- Run by
- Medical University Of Vienna
See details and how to join2024-517106-28-00 · EU 2024-517106-28-00 - 1/2. fázisTaking peopleClofarabine Therapy in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 50
- Run by
- Medical University Of Vienna
See details and how to join2024-516586-37-00 · EU 2024-516586-37-00 - 3. fázisNot yet taking people in AusztriaSingle-Dose Intravesical Chemotherapy After Diagnostic URS
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 394
- Run by
- David D'Andrea
See details and how to joinNCT05810623 - No phaseTaking peopleMulticentric Prospective T1 Urinary Bladder Cancer Registry
- Where
- Vienna
- Életkor
- 18 év to 90 év
- People
- 700
- Run by
- Medical University of Vienna
See details and how to joinNCT05792033